title: Predictive value of complement activation fragments C3a and sC5b-9 for development of severe disease in patients with acute pancreatitis.
abstract: BACKGROUND
  Complement activation has been shown to occur in patients with acute pancreatitis. However, the diagnostic potential of complement activation products in plasma for predicting severe disease remains unclear to date.
  
  
  METHODS
  The daily levels of the complement anaphylatoxin C3a and the soluble terminal complement complex sC5b-9 were determined by ELISA in plasma of patients with mild (n = 16) or severe (n = 14) acute pancreatitis during the first week after onset of symptoms, and in healthy control subjects (n = 14).
  
  
  RESULTS
  Both C3a and sC5b-9 were significantly elevated during the first 7 days in plasma of patients with severe acute pancreatitis (C3a: 459.3 +/- 407.5 ng/mL (mean +/- s); sC5b-9: 617.9 +/- 297.7 ng/mL), as compared to patients with mild disease (C3a: 172 +/- 149.5 ng/mL; sC5b-9: 306.7 +/- 167.3 ng/mL) or controls (C3a: 102.3 +/- 19.7 ng/mL; sC5b-9: 40.64 +/- 19.7 ng/mL; P < 0.001, repeated measures ANOVA). The analysis of both parameters in combination during the first week after onset of symptoms revealed a high sensitivity (0.93) and specificity (0.88) as well as high negative and positive predictive values (0.93 and 0.87, respectively) with an odds ratio of 91.0 for the development of pancreatic necrosis (P < 0.0001, Fisher exact test).
  
  
  CONCLUSIONS
  In patients with acute pancreatitis, the plasma levels of complement C3a and sC5b-9 measured daily during the first week after onset of symptoms represent highly specific and sensitive parameters for the prediction of severe acute pancreatitis.
authors: Dept. of Visceral and Transplantation Surgery, University of Bern, Switzerland.
authors: B
authors: B
authors: Gloor
authors: P F
authors: PF
authors: Stahel
authors: C A
authors: CA
authors: Müller
authors: O I
authors: OI
authors: Schmidt
authors: M W
authors: MW
authors: Büchler
authors: W
authors: W
authors: Uhl
mesh_terms: D000208:Acute Disease; D015926:Complement C3a / Q000032:analysis*; D015938:Complement Membrane Attack Complex / Q000032:analysis*; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010195:Pancreatitis / Q000097:blood / Q000175:diagnosis* / Q000276:immunology; D011237:Predictive Value of Tests; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index
chemical_list: D015938:Complement Membrane Attack Complex; D015926:Complement C3a